Risk Factors for Severe COVID-19 in Patients with Multiple Sclerosis
There may be numerous risk factors and outcomes associated with SARS-CoV-2 infection in patients with multiple sclerosis.
Multiple Sclerosis
Tongue-Delivered Neuromodulation Therapy Gets FDA Clearance for MS-Related Gait Deficit
PoNS is a portable, noninvasive, prescription-only device intended to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older.
Elevated Serum GFAP Predicts MS-Associated Diffuse White Matter Damage
Investigators sought to better understand the pathological correlates associated with increased serum GFAP in the normal appearing white matter of patients with multiple sclerosis.
Clinical Characteristics, MRI Markers Predict Worsening Cognition Over 10 Years in MS
Study researchers examined whether baseline MRI-markers and demographic and clinical data can help predict cognitive worsening patients with multiple sclerosis.
Greater Disability Tied to Worse COVID-19 Severity in MS Patients
Ambulatory disability and older age are associated with worse clinical severity of COVID-19, including death, among patients with MS.
Age May Modulate Relapse Frequency and Phenotypic Presentation of MS
A team of researchers assessed the Novartis-Oxford Multiple Sclerosis data set to investigate the relationship between age, relapse frequency, and phenotypic presentation of multiple sclerosis.
Increased Vascular Comorbidities Linked to Decreased Neuroperformance in MS
Vascular comorbidity burden among patients with multiple sclerosis may be associated with neurologic dysfunction and neurodegeneration.
Baseline and Follow-Up MRI Predictors of Long-Term Prognosis in Pediatric MS
A baseline MRI assessment and subsequent clinical and MRI monitoring during the first 2 years of pediatric multiple sclerosis onset can likely provide insights into 9-year prognosis.
Ponvory Approved for Relapsing Forms of Multiple Sclerosis
Ponesimod is a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator.
Multiple Sclerosis and Major Depressive Disorder Share Little Genetic Liability
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
-
Loading...
-
Loading...
Next post in Multiple Sclerosis
